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Objectives. This study was aimed at assessing both stimulated
insulinemia and the sodium–lithium countertransport in a se-
lected group of patients with cardiac syndrome X.
Background. Hyperinsulinemia, which is frequently present in
patients with cardiac syndrome X, is often associated with an
enhanced activity of the sodium–lithium countertransport, an in
vitro marker of sodium–hydrogen exchange.
Methods. Fifteen patients with syndrome X and 14 matched
controls were studied. After pharmacological washout, sodium–
lithium countertransport was assessed from lithium-loaded red
blood cells. Postload insulin levels were evaluated by a double-
antibody radioimmunoassay.
Results. Maximal velocity of sodium–lithium countertransport
was higher in patients with syndrome X compared to controls
(635 6 200 vs. 324 6 49 mmol/liter/h, p 5 0.001). Fourteen of the
15 patients with syndrome X (93%) presented sodium–lithium
countertransport values higher than the mean 12 SD of the
control group. At 120 min, 12 patients with syndrome X (80%) had
plasma levels of insulin >420 pmol/liter, which corresponds to the
mean value 12 SD of controls (p 5 0.006).
Conclusions. Both enhanced activity of the sodium–lithium
countertransport and stimulated hyperinsulinemia are present in
the vast majority of patients with cardiac syndrome X. As en-
hanced activity of the sodium–lithium countertransport has the
potential to cause both glucose intolerance and smooth muscle
hyperreactivity, it might represent a common cause of the meta-
bolic and vascular alterations frequently found in syndrome X.
(J Am Coll Cardiol 1998;32:2031–4)
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Syndrome X describes patients with anginalike chest pain,
noninvasive tests suggestive of myocardial ischemia, and an-
giographically normal coronary vessels with no evidence of
inducible coronary artery spasm, in the absence of known
associated cardiovascular disorders. Coronary prearteriolar
dysfunction has been proposed as the cause of angina (1,2).
Furthermore, hyperinsulinemia is frequently present in pa-
tients with syndrome X (3,4), thus suggesting that a metabolic
disorder may play a role in the pathogenesis of this syndrome.
However, the link between microvascular dysfunction and
hyperinsulinemia is still elusive. Interestingly, in about one-
third of patients with hypertension or non-insulin-dependent
diabetes mellitus, hyperinsulinemia is associated with an en-
hanced activity of the red blood cell sodium–lithium counter-
transport (Na-Li CT) (5), which reflects the activity of the
sodium–hydrogen exchange (6). The latter plays a major role
in intracellular pH and calcium homeostasis (7). Stimulation of
sodium–hydrogen exchange determines an increase in intra-
cellular calcium concentration, which, in turn, causes an in-
crease of vascular tone and of reactivity to vasoconstrictor
stimuli (8). Early studies, carried out by ourselves (9,10) and
others (11), have suggested the presence of an alteration of
Na-Li CT and sodium–hydrogen exchange in patients with
syndrome X.
In the attempt to understand the causes of syndrome X, red
blood cell Na-Li CT activity and stimulated insulinemia were
assessed in a well-selected group of consecutive patients with
syndrome X.
Methods
Study populations. Patients with syndrome X. This group
consisted of 15 consecutive patients (14 women; mean age:
54 6 6 years) referred to our institution for suspected coronary
artery disease, and who met the following criteria: recurrent
chest pain at rest and on effort; normal electrocardiogram
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(ECG) at rest; repeatedly positive exercise test for ischemiclike
ECG changes (horizontal or downsloping ST-segment depres-
sion .1.5 mm at 60 ms from J-point in at least two contiguous
leads lasting more than 1 min); normal left and right ventric-
ular function at rest and no evidence of valvular heart disease
nor of myocardial hypertrophy at echocardiography; rest sys-
tolic/diastolic blood pressure ,140/90 mm Hg in the absence
of any medications; no history nor heredity of diabetes; glucose
intolerance or hypertension; a recent (,12 months) normal
coronary angiogram without evidence of focal or diffuse coro-
nary spasm after intracoronary administration of ergonovine
maleate. Thallium-201 scintigraphy was positive for adenosine-
induced regional uptake abnormalities in 12 patients. Meno-
pause was present in seven women, five of which had had
surgical hysterectomy.
Control group. This group consisted of 14 healthy subjects
(13 women; mean age: 47 6 15 years), without hypertension
and/or diabetic heredity, matched to the patients with syn-
drome X for age, gender and body mass index (Table 1). All
controls were recruited among hospital personnel and had
normal physical examination, rest ECG, chest radiogram,
echocardiogram and exercise stress test. Menopause was
present in six women. None were taking medication.
Biochemical analysis. All biochemical analyses were per-
formed after 10 days of therapy discontinuation.
Sodium–lithium countertransport. The Na-Li CT was as-
sessed from lithium-loaded red blood cells according to the
well-accepted method of Canessa et al. (12). Briefly, red blood
cells were separated within 3 h by centrifugation for 10 min at
300 g. After separation, red blood cells were then washed three
times in a sodium-containing washing solution (in mmol/liter):
magnesium chloride 75, sucrose 85, glucose 10, and Tris-
MOPS 10, pH 7.4 at 4°C, and the maximum velocity (Vmax) of
the Na-Li CT was assessed from the external sodium-
stimulated lithium efflux after lithium loading.
Glucose tolerance test. Patients and control subjects fol-
lowed their habitual diet until the morning of the study day.
After an overnight fast, they were given a glucose solution to
drink (75 mg in 200 ml water). Venous blood samples were
taken during fasting and at 30, 60, 90, 120 and 180 min after the
oral glucose load. Plasma glucose levels were assessed by an
Analox microsat autoanalyzer using the glucose oxidase/
peroxidase method. Immunoreactive insulin levels were deter-
mined using Pharmacia Insulin radioimmunoassay kit (Phar-
macia Diagnostics AB, Uppsala, Sweden).
Statistical analysis. Continuous normally distributed data
are expressed as mean 6 1 SD and were analyzed by two-tailed
unpaired Students’ t test. Data on insulin, which are not
normally distributed, are expressed as median and interquar-
tile range. Chi-square test with continuity correction was
applied to compare proportions. Repeated measures analysis
of variance was used to compare the two groups over time
regarding plasma concentrations of glucose and insulin; for a p
value ,0.05 pairwise comparisons were performed by using
Scheffe F test and Mann–Whitney rank-sum test as appropri-
ate. Differences between groups were considered to be statis-
tically significant at a p value ,0.05.
Results
Sodium–lithium countertransport. The Na-Li CT was sig-
nificantly higher in patients with syndrome X compared to
controls (635 6 200 vs. 324 6 49 mmol/liter/h, p 5 0.001) (Fig.
1). Of note, 14 of the 15 patients with syndrome X (93%)
presented Na-Li CT values higher than the mean 12 SD of the
control group (which correspond to 97.5% of the normal
population).
Glucose tolerance test. Fasting plasma glucose was normal
in all patients with syndrome X and controls, and there was no
significant difference among the two groups at all sampling
points during the tolerance test. Fasting plasma insulin was
higher in patients with syndrome X than in controls, but the
difference did not reach statistical significance. At 30, 60, 90,
120 and 180 min, plasma insulin levels were higher in patients
with syndrome X than in controls (Table 2). At 120 min, 12
patients with syndrome X (80%) had plasma levels of insulin
higher than 420 pmol/liter, which corresponds to the mean
value 12 SD of our control population (p 5 0.006).
Figure 1. Sodium–lithium countertransport activity in red blood cells
of patients with syndrome X and controls.
Table 1. Demographic and Clinical Characteristics of the
Study Groups
Characteristics
Syndrome X
(n 5 15)
Controls
(n 5 14)
Women (no.) 14 13
Age (yrs) 54 6 6* 47 6 15
Body mass index (kg 3 m22) 24.5 6 4.6 24.7 6 4.3
Smoker (no.) 6 6
Menopause (no.) 7 6
Symptom duration (months) 44 6 14 —
Hemodynamic data
Systolic blood pressure (mm Hg) 125 6 10 128 6 9
Diastolic blood pressure (mm Hg) 74 6 9 76 6 10
Heart rate (bpm) 75 6 9 72 6 8
Ejection fraction (%) 72 6 8 70 6 9
Exercise test
Exercise duration (s) 696 6 176 717 6 134
Peak rate-pressure
Product (102 3 min Hg 3 min21) 284 6 89 278 6 96
Time to 0.1 mV ST depression (s) 569 6 186 —
*Plus-minus values are means 6 SD.
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Discussion
The results of our study indicate that the vast majority of
patients with cardiac syndrome X exhibit an enhanced activity
of the Na-Li CT, an in vitro marker of the sodium–hydrogen
exchange activity (5,6). An influence of medications on Na-Li
CT can be ruled out as patients discontinued therapy 10 days
before the assay, which was performed on washed red blood
cells (13).
The sodium–hydrogen exchange represents the most im-
portant cellular system in the control of intracellular pH and
plays a major role in the regulation of cellular calcium ho-
meostasis (7). The demonstration of an enhanced activity of
the sodium–hydrogen exchange provides a clue to link to-
gether the many and apparently different dowels of this
intriguing syndrome. Indeed, coronary prearteriolar dysfunc-
tion, hyperinsulinemia and the predominance of sympathetic
activity commonly observed in patients with syndrome X may
all be explained by an enhanced activity of the sodium–
hydrogen exchange.
Stimulation of sodium–hydrogen exchange results in alka-
linization of intracellular medium and in an increase of
intracellular-free calcium concentration (7). These changes, in
turn, may cause an increase of coronary microvascular tone
and an enhanced susceptibility to vasoconstrictor agents (14).
Furthermore, the frequent occurrence of myocardial hyper-
contractility (15), abnormal esophageal motility (16), airway
hyperreactivity (17) and reduced forearm vasodilator reserve
(18) in patients with syndrome X may be due to the ubiquity of
this pump, which is expressed in cardiac and smooth muscle
cells.
An elevated Vmax of red blood cell Na-Li CT, along with its
effects on intracellular calcium concentration, has been indi-
cated as a functional abnormality involved in the pathogenesis
of insulin resistance and hyperinsulinemia (19). The latter, in
turn, may enhance coronary microvascular dysfunction
through an alteration of endothelial function (20).
Finally, a number of clinical studies have demonstrated a
predominance of sympathetic activity in patients with syn-
drome X (21), which could enhance coronary prearteriolar
dysfunction and sensitize small coronary arteries to vasocon-
strictor stimuli (22). Of note, an increase of intracellular
sodium concentration, mediated by an enhanced activity of the
sodium–hydrogen pump, causes a reduction of type I cathe-
cholamine reuptake with consequent increase of extracellular
cathecholamine concentration (23). This observation accords
with the recent demonstration of massive regional defects in
[123I]metaiodobenzylguanidine myocardial uptake, a cathe-
cholamine analogue, in the majority of patients with syndrome
X (24). Furthermore, insulin promotes norepinephrine release
within the forearm tissues and enhances vascular responsive-
ness by activating the sympathetic nervous system (25).
Study limitations. A limitation of the present study is that
quantitative relationship among Na-Li CT, hyperinsulinemia
and coronary microvascular dysfunction was not specifically
investigated; of note, in patients with cardiac syndrome X,
coronary microvascular dysfunction appears to be limited to
very small myocardial regions and difficult to investigate quan-
titatively by using conventional techniques (26,27). Another
potential limitation is that the enhanced Na-Li CT may
represent an epiphenomenon secondary to impaired physical
activity in patients with syndrome X. However, exercise toler-
ance, a surrogate of physical capacity, was similar in patients
with syndrome X and in controls.
Conclusions. Both enhanced activity of the Na-Li CT and
stimulated hyperinsulinemia are present in the vast majority of
patients with cardiac syndrome X. As enhanced activity of the
Na-Li CT has the potential to cause both glucose intolerance
and smooth muscle hyperreactivity, it might represent a com-
mon link between metabolic and vascular alterations fre-
quently found in patients with syndrome X.
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